- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
UPDATED Apr 24, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
99 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ATAT | US$18.43 | 8.3% | -14.6% | US$2.4b | US$28.23 | PE24.9x | E28.0% | n/a | Consumer Services | ||
STRA | US$100.65 | 2.6% | 8.9% | US$2.4b | US$124.25 | PE35.1x | E30.2% | 2.4% | Consumer Services | ||
OSIS | US$139.71 | 3.7% | 36.3% | US$2.4b | US$162.25 | PE21x | E16.2% | n/a | Tech | ||
CORT | US$22.48 | -2.3% | 1.1% | US$2.4b | US$42.80 | PE22.1x | E25.9% | n/a | Pharmaceuticals & Biotech | ||
NABL | US$12.33 | 1.6% | -3.4% | US$2.3b | US$15.46 | PE97.3x | E30.0% | n/a | Software | ||
LAUR | US$14.32 | 1.8% | 17.8% | US$2.2b | US$17.67 | PE19.2x | E21.1% | 4.9% | Consumer Services | ||
PRVA | US$18.17 | 1.8% | -30.8% | US$2.2b | US$27.28 | PE93.4x | E26.4% | n/a | Healthcare | ||
PAX | US$13.93 | 3.4% | -4.3% | US$2.1b | US$19.11 | PE17.7x | E27.5% | 7.1% | Diversified Financials | ||
CRTO | US$36.96 | 8.5% | 20.9% | US$2.0b | US$37.29 | PE38.3x | E24.6% | n/a | Media | ||
ODD | US$31.97 | -7.5% | n/a | US$1.9b | US$53.14 | PE31.1x | E21.2% | n/a | Household | ||
DHT | US$11.28 | 0% | 19.9% | US$1.8b | US$13.67 | PE11.3x | E16.4% | 8.8% | Energy | ||
ARRY | US$12.23 | 9.5% | -39.8% | US$1.8b | US$20.22 | PE21.7x | E21.7% | n/a | Capital Goods | ||
ASTH | US$37.01 | -1.1% | 4.3% | US$1.8b | US$54.00 | PE29.4x | E17.3% | n/a | Healthcare | ||
PLAB | US$27.51 | 3.7% | 94.0% | US$1.7b | US$32.00 | PE12.7x | E25.7% | n/a | Semiconductors | ||
ACMR | US$28.15 | 0.9% | 194.5% | US$1.7b | US$37.95 | PE22.2x | E16.1% | n/a | Semiconductors | ||
HRMY | US$29.23 | 0.1% | -7.7% | US$1.6b | US$41.50 | PE12.9x | E25.8% | n/a | Pharmaceuticals & Biotech | ||
THRM | US$50.74 | 0.5% | -10.6% | US$1.6b | US$69.00 | PE39.8x | E45.4% | n/a | Automobiles | ||
HG | US$14.20 | 6.3% | n/a | US$1.6b | US$19.67 | PE6x | E18.1% | n/a | Insurance | ||
GCT | US$35.91 | 2.7% | 597.3% | US$1.5b | US$40.50 | PE15.6x | E22.1% | n/a | Retail | ||
SKWD | US$36.24 | 4.6% | 72.2% | US$1.5b | US$42.63 | PE17.2x | E15.5% | n/a | Insurance | ||
ANIP | US$65.43 | -0.08% | 74.0% | US$1.4b | US$79.80 | PE88.7x | E37.4% | n/a | Pharmaceuticals & Biotech | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | Pharmaceuticals & Biotech | ||
CDRE | US$33.43 | 1.0% | 60.7% | US$1.3b | US$42.67 | PE34.4x | E15.7% | 1.0% | Capital Goods | ||
PCRX | US$25.90 | -3.2% | -41.2% | US$1.2b | US$45.73 | PE28.7x | E29.3% | n/a | Pharmaceuticals & Biotech |